Benign myoclonic epilepsy in infancy with preceding afebrile generalized tonic-clonic seizures in Japan

Susumu Ito1, Hirokazu Oguni, Makiko Osawa

  • 1Department of Pediatrics, School of Medicine, Tokyo Women's Medical University, Shinjuku-ku, Japan. itos@ped.twmu.ac.jp

Brain & Development
|March 6, 2012
PubMed

Insights

Benign myoclonic epilepsy in infancy (BMEI) can present with early generalized tonic-clonic seizures (GTCS) before myoclonic seizures (MS). This finding expands the recognized spectrum of BMEI, showing similar outcomes to typical cases.

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Epileptology

Background:

  • Benign myoclonic epilepsy in infancy (BMEI) is typically characterized by myoclonic seizures (MS) in infants under three years old.
  • While later generalized tonic-clonic seizures (GTCS) are known in BMEI, early GTCS preceding MS have not been recognized.
  • This challenges the established diagnostic criteria and understanding of BMEI's early presentation.

Purpose of the Study:

  • To describe a cohort of children presenting with early GTCS prior to MS.
  • To investigate if these children fit within the spectrum of BMEI.
  • To compare their seizure characteristics, outcomes, and developmental trajectories with typical BMEI cases.

Main Methods:

  • Case series reporting on seven children with BMEI presenting with GTCS before MS.
  • Clinical data collection including seizure types, age of onset, video-polygraphic features of MS, and developmental assessments.
  • Longitudinal follow-up to evaluate seizure course and developmental outcomes.

Main Results:

  • Seven children presented with recurrent GTCS before the onset of MS, fulfilling other BMEI criteria.
  • The age of MS onset, ictal features, and long-term seizure and developmental outcomes were comparable to typical BMEI.
  • The early GTCS were transient, often resolving within months and being replaced by MS.

Conclusions:

  • Children experiencing early GTCS followed by MS may represent a distinct subgroup of BMEI.
  • This finding broadens the clinical spectrum of BMEI, suggesting a more varied early presentation.
  • Recognition of this BMEI variant is crucial for accurate diagnosis and management in pediatric epilepsy.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures ll: Types01:19

Seizures ll: Types

Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...